Details

Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč : doktorska disertacija
ID Koren, Ana (Author), ID Čufer, Tanja (Mentor) More about this mentor... This link opens in a new window, ID Korošec, Peter (Comentor)

.pdfPDF - Presentation file, Download (2,09 MB)
MD5: A9F73324DEF993114265803B781F0EBD
PID: 20.500.12556/rul/d6454d84-3e5f-43c0-a05f-848327dd79a0

Language:Slovenian
Keywords:onkologija, nedrobnocelični karcinom pljuč, matične celice novotvorb, epitelno-mezenhimski prehod, prognoza, cirkulirajoče celice novotvorb, biološki tumorski označevalci
Work type:Dissertation
Typology:2.08 - Doctoral Dissertation
Organization:MF - Faculty of Medicine
Place of publishing:Ljubljana
Publisher:[A. Koren]
Year:2016
Number of pages:XVI, 93 str.
PID:20.500.12556/RUL-84295 This link opens in a new window
UDC:616.24-006(043.3)
COBISS.SI-ID:284476416 This link opens in a new window
Publication date in RUL:29.07.2016
Views:4039
Downloads:1044
Metadata:XML DC-XML DC-RDF
:
KOREN, Ana, 2016, Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč : doktorska disertacija [online]. Doctoral dissertation. Ljubljana : A. Koren. [Accessed 1 April 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=84295
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:The importance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer : doctoral dissertation
Keywords:oncology, carcinoma non-small-cell lung, neoplastic stem cells, epithelial-mesenchymal transition, prognosis, neoplastic cells circulating, biomarkers tumor

Similar documents

Similar works from RUL:
  1. Review of the treatment of advanced non-small-cell lung cancer patients with mutation in the epidermal growth factor during the years of 2010 and 2014 at the University Clinic Golnik
  2. Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
  3. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Epidermal growth factor receptor mutations and treatment of non-small-cell lung cancer
  2. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  3. Multicenter evaluation of the fully automated PCR-based Idylla EGFR Mutation Assay on formalin-fixed, paraffin-embedded Q1 tissue of human lung cancer
  4. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  5. Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer

Back